Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Ashwagandha and Reduced Anxiety

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of ashwagandha on anxiety, with a predominant moderate effect size. 3 of the 4 studies found statistically significant results. The most robust evidence comes from a meta-analysis showing a large effect (SMD: -1.13) in clinical populations at a median dose of 600 mg/day over 56 days, and a systematic review (590 participants) found moderate benefits across mixed populations at doses of 120–1000 mg/day.

  • Effective dose range: 120–1000 mg/day, with a converging median dose of 600 mg/day
  • Studied populations: healthy individuals, people with stress-related or functional disorders, and clinical populations with any mental disorder

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Form data were not extracted, so differential effects by form cannot be assessed; most studies did not specify the ashwagandha form used.

Generated Jul 12, 2026
Doses used in studies
  • mg/day: 120–1,000 (median 580, IQR 240900) 2 studies
Time to effect
Median: 8 weeks · IQR 8 weeks8 weeks · Range 8 weeks8 weeks — Reported in 1 of 4 studies
Safety in these studies
4 of 4 papers
Back to top